Nicholas Lambrou, MD
Gynecologic Oncology · Annapolis, MDNPI 1831113950
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.3%), education and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 45.1% of the total. Reporting peaked in 2019 at $23,323 and has fallen 90.6% since, to $2,202 in 2025. Among gynecologic oncology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $511.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$37K
- Intuitive Surgical$30K
- AstraZeneca$5K
- Ethicon Endo-surgery Inc.$4K
- Seagen Inc.$2K
- Medical Device Business Services, Inc.$1K
- plus $3K from 12 others
What the payments were for
- Consulting fees$41,66050%
- Speaking & faculty fees$11,30014%
- Travel & lodging$11,15413%
- Food & beverage$6,4818%
- Education$12,00014%
- Gifts$1950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 46 | $37,300 |
| Intuitive Surgical | 52 | $30,118 |
| AstraZeneca | 2 | $5,480 |
| Ethicon Endo-surgery Inc. | 8 | $4,280 |
| Seagen Inc. | 1 | $1,575 |
| Medical Device Business Services, Inc. | 7 | $1,072 |
| AbbVie | 14 | $1,020 |
| Baxter Healthcare | 7 | $596 |
| GSK | 7 | $409 |
| Conmed Corporation | 5 | $383 |
| Eisai Inc. | 6 | $255 |
| Covidien LP | 1 | $100 |
| Hologic Sales And Service, LLC | 1 | $86 |
| Pfizer | 1 | $29 |
| Merck | 1 | $28 |
| Corcept Therapeutics | 1 | $25 |
| Kerecis Limited | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$29,047
- ECHELON ENDOPATH Stapler$12,249
- ECHELON FLEX Stapler$12,249
- LIGACLIP$12,249
- LYNPARZA$2,740
- TIVDAK$1,575
- Elahere$702
- TISSEEL$376
- STRATAFIX$280
- AIRSEAL$240
- PerClot$137
- ECHELON ENDOPATH$133
- Orilissa$119
- ZEJULA$117
- LENVIMA$113
- Valleylab$100
How this compares
$82,789 in reported general payments places this provider in the 90th percentile of 35 gynecologic oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Annapolis
- Christine SantayanaAnnapolis$6K
- Kevin AudlinTowson$166K
- Dwight ImBaltimore$93K
- Amanda Nickles-FaderBaltimore$21K
- Christopher TarneyBethesda$6K
- Kara Long RocheBaltimore$5K
- Neil RosensheinBaltimore$5K
- Sarah LynamBaltimore$3K
- Amanda RamosBaltimore$3K
- Beman KhulpateeaBaltimore$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.